[Selection strategy of pedicled axial flaps for repairing high-voltage electric burn wounds in foot and ankle]. [PDF]
Zhong HY +6 more
europepmc +1 more source
目的: 了解先天性心脏病(先心病)并肺动脉高压症(肺高压)术后肺高压危象的发生发展。方法: 总结 50 例 14 岁以下先心病合并中、重度肺高压病人心内畸型矫治术后的早期经过,术后出现肺高压危象情况, 其中 37 例行肺活检。结果: 术后出现肺高压危象 9例, 18次, 半数危象出现在术后 24 h 以内。中度肺高压的病人术后出现危象的比例高于重度者, 危象 倾向于多次发生。危象病人的肺活检病理 Heath-Edwards 分级均为轻、中度改变。危象的发生近半数( 44%)有呼吸道刺激的 诱因 ...
doaj
Sotatercept and pulmonary arterial hypertension. [PDF]
Tan Y, Chen Y, Li J.
europepmc +1 more source
[Cirrhotic portal hypertension reversal mechanism and its therapy]. [PDF]
Zhu CP, Xie WF.
europepmc +1 more source
肺动脉高压自1973年第一次世界研讨会以来,一直是一种具有挑战性、慢性和复杂的疾病。且肺动脉高压人群基数较大,全球约有1%的人群受到影响[1]。欧洲心脏学会(ESC)与欧洲呼吸学会(ERS)以WHO分类为基础,将肺动脉高压(PH)分为:动脉性肺动脉高压、左心疾病所致肺动脉高压(PH-LHD)、肺部疾病和(或)低氧所致肺动脉高压、慢性血栓栓塞性肺动脉高压和其他肺动脉阻塞性疾病、未明和(或)多因素所致肺动脉高压[2]。
李依朔, 杨明, 刘佳辰, 王智慧
doaj
[Role of echocardiography in the assessment of right ventricular function in pulmonary hypertension]. [PDF]
Xie Y, Tan Y, Li J.
europepmc +1 more source
[Study on the correlation between PPG and HVPG in patients with portal hypertension]. [PDF]
Wang L +11 more
europepmc +1 more source
[Clinical research progress in 2025 for hepatic fibrosis, cirrhosis, and portal hypertension]. [PDF]
Han YF, Xu XY.
europepmc +1 more source
[A neonatal intelligent regulation system based on the combination of mild hypothermia mattress and hyperbaric oxygen chamber: introduction to a patent]. [PDF]
Zhu MX +4 more
europepmc +1 more source
[NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report]. [PDF]
Yan XD, Chen YY, Tao L.
europepmc +1 more source

